ATE76757T1 - Impfstoff gegen herpes simplex. - Google Patents

Impfstoff gegen herpes simplex.

Info

Publication number
ATE76757T1
ATE76757T1 AT87301620T AT87301620T ATE76757T1 AT E76757 T1 ATE76757 T1 AT E76757T1 AT 87301620 T AT87301620 T AT 87301620T AT 87301620 T AT87301620 T AT 87301620T AT E76757 T1 ATE76757 T1 AT E76757T1
Authority
AT
Austria
Prior art keywords
virus
herpes simplex
vaccine
vaccine against
against herpes
Prior art date
Application number
AT87301620T
Other languages
English (en)
Inventor
Gordon Robert Bruce Skinner
Alexander Buchan
Original Assignee
Univ Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Birmingham filed Critical Univ Birmingham
Application granted granted Critical
Publication of ATE76757T1 publication Critical patent/ATE76757T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT87301620T 1986-03-05 1987-02-25 Impfstoff gegen herpes simplex. ATE76757T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8605390A GB8605390D0 (en) 1986-03-05 1986-03-05 Live herpes simplex vaccine
EP87301620A EP0236058B1 (de) 1986-03-05 1987-02-25 Impfstoff gegen Herpes simplex

Publications (1)

Publication Number Publication Date
ATE76757T1 true ATE76757T1 (de) 1992-06-15

Family

ID=10594056

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87301620T ATE76757T1 (de) 1986-03-05 1987-02-25 Impfstoff gegen herpes simplex.

Country Status (12)

Country Link
US (1) US5066492A (de)
EP (1) EP0236058B1 (de)
JP (1) JPS62281821A (de)
KR (1) KR870009018A (de)
AT (1) ATE76757T1 (de)
AU (1) AU596398B2 (de)
CA (1) CA1289881C (de)
DE (1) DE3779444T2 (de)
GB (1) GB8605390D0 (de)
IE (1) IE870559L (de)
IL (1) IL81734A0 (de)
ZA (1) ZA871395B (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660234A (en) * 1971-02-16 1972-05-02 Gray Ind Inc Method of attenuating viruses
US4039656A (en) * 1971-12-10 1977-08-02 Bayer Aktiengesellschaft Production of attenuated viruses
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
CA1183083A (en) * 1980-01-31 1985-02-26 William J. Mcaleer Herpes virus vaccine
US4762708A (en) * 1982-02-18 1988-08-09 University Patents, Inc. Materials and methods for herpes simplex virus vaccination
CA1201987A (en) * 1982-03-24 1986-03-18 Gordon R.B. Skinner Vaccine against dna viruses

Also Published As

Publication number Publication date
ZA871395B (en) 1987-08-17
KR870009018A (ko) 1987-10-22
AU6958987A (en) 1987-09-10
CA1289881C (en) 1991-10-01
GB8605390D0 (en) 1986-04-09
DE3779444D1 (de) 1992-07-09
IL81734A0 (en) 1987-10-20
EP0236058A2 (de) 1987-09-09
EP0236058A3 (en) 1989-01-25
EP0236058B1 (de) 1992-06-03
AU596398B2 (en) 1990-05-03
IE870559L (en) 1987-09-05
JPS62281821A (ja) 1987-12-07
US5066492A (en) 1991-11-19
DE3779444T2 (de) 1993-01-28

Similar Documents

Publication Publication Date Title
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
HU9502949D0 (en) Polipeptides, polinucleotides, vectors and host cells, and vaccines against hepatitis virus infection, diagnostics, immunoassay and culturing methods
ZA853025B (en) Isolation of proteins of htlv-iii,serological detection of antibodies to htlv-iii in sera of patients with aids and pre-aids conditions,and detection of htlv-iii infection by immuno-assays using htlv-iii and its proteins
IL132468A0 (en) A kit for inducing immune response against a tumor or a disease caused by an infection agent
NZ505322A (en) Protein expression in baculovirus vector expression systems using low multiplicity of infection
AU554080B2 (en) Production of viral antisens
ES2067921T3 (es) Una biomasa y un procedimiento para la produccion de virus/antigeno de virus.
IE860315L (en) Detecting htlv-iii neutralising antibodies
ATE76757T1 (de) Impfstoff gegen herpes simplex.
GB2353531A (en) Conditional mutants of influenza virus M2 protein
MX9602256A (es) Vacuna contra la enfermedad de marek.
EP0054058A1 (de) Menschliche osteogene sarkoma-zellinie und ihre verwendung in einem immunofluoreszierendem antikörpertest
FI923020A0 (fi) Inte a inte b-sekvenser.
MX9102757A (es) Vacuna de virus de enfermedad de marek sin celulas.
ES2052883T3 (es) Cultivo de celulas de riñon de cerdo y su uso en la produccion de vacunas.
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
DE68927380D1 (de) Impfstoff
ES8107024A1 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
ES550089A0 (es) Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.
ATE86308T1 (de) Menschlicher b-lymphotroper virus (hblv), isolierung und erzeugnisse.
AU6262786A (en) Growing aids virus in cell lines lacking human class ii histocompatability antigens
NO990325L (no) Fremstilling av immunstimulerende middel pÕ basis av propionibakterier
EP0244146A3 (de) Probe zum Nachweis von Hepatitis-A-Viren
GB1293310A (en) Vaccine
IT1227900B (it) Vaccino anti-herpes e relative composizioni farmaceutiche

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee